About Optimus Pharma Private Limited
Data last updated:
Optimus Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 September 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC044232. Its GSTIN is 36AAACO7014R1Z2 (Telangana). The company holds 8 GST registrations, of which 6 are active.
The company has an authorised share capital of ₹44 Cr and a paid-up capital of ₹37.68 Cr. It is led by directors including Srinivasareddy Desireddy and Anil Khubchandani.
Its last annual general meeting (AGM) was held on 31 January 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Raheja Mindspace IT Park, Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹81.17 Cr, a decline of 40% compared to the previous year. For the same year it recorded a net loss of ₹16.44 Cr (net margin -20.3%) and EBITDA of -₹5.87 Cr (EBITDA margin -7.2%). Revenue has declined at a compounded annual rate (CAGR) of 37% over three years and 6% over five years.
The company has about 261 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Rantus Pharma and Optimus Pharma. As per MCA filings, the company has open charges of ₹21.8 Cr and satisfied charges of ₹44.97 Cr on record. Court records list 19 cases involving the company, including 5 filed by the company and 11 filed against it; 10 cases are pending. The company has 21 deals on record (12 secondary share transfers, 6 funding rounds, 3 rights issues), with disclosed funding of ₹36.65 Cr; the latest was in September 2023. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is JFL Life Sciences Limited with revenue of ₹82.05 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2023, listing 207 overdue payments to 47 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website optimuspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address7th Floor Maximus Towers 2A, Raheja Mindspace IT Park Hitec City, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Optimus Pharma Private Limited
The main business activity of Optimus Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Optimus Pharma Private Limited FY 2024 filings available
Optimus Pharma Private Limited reported revenue of ₹81.17 Cr (down 40% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Optimus Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 40% fall in the latest year. EBITDA rose 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Optimus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹5.87 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹16.44 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Optimus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -20.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Optimus Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Optimus Pharma Private Limited
Optimus Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JFL Life Sciences Limited | ₹82.05 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Ahmedabad, Gujarat, India |
| Oscar Remedies Pvt Ltd | ₹82.04 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Haryana, India |
| Sun Life Sciences Private Limited | ₹81.57 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Bangalore, Karnataka, India |
| Indian Drugs and Pharmaceuticals Limited | ₹81.46 Cr (FY 2015) | •••• | •••• | 7.0% | •••• | Gurgaon, Haryana, India |
| Alde Medi Impex Limited | ₹81.34 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | New Delhi, Delhi, India |
| Optimus Pharma Private Limited this company | ₹81.17 Cr (FY 2025) | •••• | •••• | -40.0% | •••• | Hyderabad, Telangana, India |
| Nitika Pharmaceutical Specialities Private Limited | ₹80.91 Cr (FY 2024) | •••• | •••• | 35.0% | •••• | Nagpur, Maharashtra, India |
| Lividus Pharmaceuticals Private Limited | ₹80.9 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Karunagappally, Kerala, India |
| Endoc Lifecare Private Limited | ₹80.74 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Rajkot, Gujarat, India |
| Nikvin Healthcare (India) Private Limited | ₹80.65 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | New Delhi, Delhi, India |
| Adroit Pharmaceuticals Private Limited | ₹80.51 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Optimus Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Optimus Pharma Private Limited
Optimus Pharma Private Limited is audited by B S R and Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S R and Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Optimus Pharma Private Limited
Optimus Pharma has 8 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Ownership and Shareholding of Optimus Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Optimus Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2016 | Others | ₹21.8 Cr | Open |
| 06 Nov 2020 | Others | ₹3.8 Cr | Satisfied |
| 13 Feb 2020 | Others | ₹20 Cr | Satisfied |
| 12 Oct 2011 | Standard Chartered Bank | ₹11.5 Cr | Satisfied |
| 12 Oct 2011 | Standard Chartered Bank | ₹25 Lakh | Satisfied |
Total charge records: 9 View all charges
Deals & Funding of Optimus Pharma Private Limited
Optimus Pharma Private Limited has 21 deals on record (12 secondary share transfers, 6 funding rounds, 3 rights issues), with disclosed funding of ₹36.65 Cr; the latest was in September 2023.
Deals on record (5 of 21)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2023 | Secondary share transfer | Undisclosed | Buyer: Optimus Drugs Private Limited & Ashwin Trinidad, Optimus Drugs Private Limited Seller: Optimus Drugs Private Limited , 2 individuals |
| Mar 2023 | Rights issue | ₹50 Cr | Investors: Optimus Drugs Private Limited |
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Srinivas Reddy Desireddy HUF, an individual |
| Dec 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: Optimus Drugs Private Limited Seller: Optrix Laboratories Private Limited |
Full deal history
All 21 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Optimus Pharma Private Limited
Optimus Pharma Private Limited has 19 court cases on record: 5 filed by Optimus Pharma, 11 filed against it, 3 where it is another party. 10 cases are pending and 9 are disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 18 | 10 | 9 |
| District courts | 1 | 1 | 1 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (FAO(OS)) | Filed against the company by Symed Labs Limited | Disposed |
| High Court of Himachal Pradesh | Court case (OMP) | Filed against the company by Boehring Ingelheim Pharma GMBH and Co. KG | Pending |
| High Court of Himachal Pradesh | Interim or miscellaneous application | Filed by the company against Boehringer Ingelheim Pharma GMBH and Co. KG | Pending |
| High Court of Himachal Pradesh | Commercial suit | Filed against the company by Boehring Ingelheim Pharma GMBH and Co. KG | Pending |
| District court, Muzaffarpur, Bihar | Court case (Drugs and Cosmetics Act) | Filed against the company by State of Bihar | Pending |
Full case history
All 19 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Optimus Pharma Private Limited
Optimus Pharma Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 207 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 47)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| C N Tech Engineers Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 14 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Optimus Pharma Private Limited
Optimus Pharma operates two associated brands: Rantus Pharma and Optimus Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures active pharmaceutical ingredients and intermediates. | rantuspharma.com | |
| APIs, advanced intermediates, and formulations are manufactured. | optimuspharma.com |
Employees and EPFO Compliance at Optimus Pharma Private Limited
Optimus Pharma Private Limited has a workforce of 261 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Optimus Pharma Private Limited
Optimus Pharma has one previous CIN (Corporate Identification Number): U24239AP2004PTC044232. The current CIN is U24239TG2004PTC044232, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC044232 | Current |
| U24239AP2004PTC044232 | Previous |
Recent Activity on Optimus Pharma Private Limited
Optimus Pharma Private Limited has 21 board changes on record since 2004: 8 appointments and 13 cessations. The latest: Santosh Kumar Mahil ceased to be Additional Director on 05 Sep 2025.
34 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Optimus Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Optimus Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Optimus Pharma Private Limited
Optimus Pharma has 8 GST registrations: 6 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACO7014R1Z2 | Telangana | Active | 01 Jul 2017 |
| 36AAACO7014R2Z1 | Telangana | Active | 01 May 2024 |
| 02AAACO7014R1ZD | Himachal Pradesh | Active | 01 Jul 2017 |
| 05AAACO7014R1Z7 | Uttarakhand | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Optimus Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Optimus Pharma Private Limited
Frequently Asked Questions about Optimus Pharma Private Limited
Optimus Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 September 2004 (22+ years old) and is registered under CIN U24239TG2004PTC044232.
Optimus Pharma reported revenue of ₹81.17 Cr for FY 2025 (down 40% YoY).
Optimus Pharma has 8 current directors:
- Srinivasareddy Desireddy - Director
- Anil Khubchandani - Director
- Lakshay Kataria - Additional Director
- Pagadala Baskarannarayanan - Director
- Santosh Kumar Mahil - Director
- Sumit Mohan Nadgir - Director
- Harsha Vardhana Reddy Poluru - Director
- Uma Rao - Director
Optimus Pharma reported a net loss of ₹16.44 Cr (net margin -20.3%) and EBITDA of -₹5.87 Cr (EBITDA margin -7.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Optimus Pharma is -37% over three years and -6% over five years. In the latest year (FY 2025) revenue fell 40%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Optimus Pharma is 36AAACO7014R1Z2, registered in Telangana. The company has 8 GST registrations in all, of which 6 are active and 2 are cancelled or inactive. Other active GSTINs include 36AAACO7014R2Z1 (Telangana), 02AAACO7014R1ZD (Himachal Pradesh), 05AAACO7014R1Z7 (Uttarakhand).
The CIN (Corporate Identification Number) of Optimus Pharma is U24239TG2004PTC044232. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Optimus Pharma has 19 court cases on record: 5 filed by the company and 11 filed against it. 10 are pending. Most are in the high courts.
Optimus Pharma was incorporated on 21 September 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Optimus Pharma has 21 deals on record (12 secondary share transfers, 6 funding rounds, 3 rights issues), with disclosed funding of ₹36.65 Cr; the latest was in September 2023.
The peers of Optimus Pharma by revenue are JFL Life Sciences Limited, Oscar Remedies Pvt Ltd, Sun Life Sciences Private Limited, Indian Drugs and Pharmaceuticals Limited, Alde Medi Impex Limited and 5 more, all in the Pharma industry (Formulations).
Santosh Kumar Mahil ceased to be Additional Director on 05 Sep 2025. Sumit Mohan Nadgir ceased to be Additional Director on 05 Sep 2025. Lakshay Kataria ceased to be Additional Director on 26 Jun 2025. Optimus Pharma has 21 board changes on record in total.